3.6. Analysis.

Comparison 3 BPO versus clindamycin, Outcome 6 Investigator‐assessed percentage change in inflammatory lesions (long‐term data).

Comparison 3 BPO versus clindamycin, Outcome 6 Investigator‐assessed percentage change in inflammatory lesions (long‐term data).